C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01) A61K 31/495 (2006.01) A61K 45/06 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2387351
The present invention relates to compounds of Formula I which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals. (see formula I)
La présente invention se rapporte à des composés qui inhibent, régulent et/ou modulent la transduction des signaux de tyrosine kinases, à des compositions qui contiennent ces composés et à des procédés d'utilisation de ces composés pour traiter des maladies et des troubles dépendant des tyrosine kinases, tels que l'angiogenèse, le cancer, la croissance tumorale, l'athérosclérose, la dégénérescence maculaire liée à l'âge, la rétinopathie diabétique, des maladies inflammatoires et analogues, chez des sujets mammifères.
Arrington Kenneth L.
Bilodeau Mark T.
Fraley Mark E.
Hartman George D.
Hoffman William F.
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
LandOfFree
Indole derivatives as tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole derivatives as tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives as tyrosine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1370052